|
Volume 1 Number 3 |
August 1995 |
|
The diaphragm |
69-70 |
||
|
Success in the management of asthma: a lesson from NZ |
71 |
||
|
Nebulized versus intravenous salbutamol in acute severe asthma |
72 |
||
|
Findings before the diagnosis of asthma in young adults |
73 |
||
|
Air pollution and bronchial hyperresponsiveness in schoolchildren |
74 |
||
|
Once daily inhaled corticosteroids in stable asthma? |
75 |
||
|
Is salmeterol-beclomethasone combined therapy superior to higher doses of beclomethasone in moderate asthma? |
76 |
||
|
Is house dust mite allergen avoidance effective? |
77 |
||
|
Reversible change in FEV1 during an acute respiratory tract infection |
78 |
||
|
Smoking-cessation programmes are effective in reducing the rate of decline in FEV1 in early stages of COPD |
79 |
||
|
Consequences of passive smoking in adults |
80 |
||
|
Smoking as a risk factor for sleep disordered breathing |
81 |
||
|
Noninvasive positive pressure ventilation in respiratory failure: a critical review of the literature |
82-83 |
||
|
Is snoring really a cause of systemic hypertension? |
84 |
||
|
Respiratory infections with Chlamydia pneumoniae in elderly adults |
85 |
||
|
Should we monitor liver function during antituberculous therapy |
86 |
||
|
Management of the acute respiratory distress syndrome |
87 |
||
|
Lung function in adolescents with alpha1-antitrypsin deficiency |
88 |
||
|
Breast cancer treatment and pulmonary disease |
89 |
||
|
Can quantitative CT predict postoperative lung function in patients with lung cancer? |
90 |
||
|
Mortality from mesothelioma |
91 |
||
|
Asbestos, asbestosis and lung cancer |
92 |
||
|
Chemotherapy and surgery in resectable stage IIIA non-small-cell lung cancer (NSCLC): time for a change? |
93 |
||
|
Prophylactic cranial irradiation for patients with small-cell lung cancer: is it worth it? |
94 |
||
|
Combined use of bronchial aspirates and biopsy specimens in diagnosis and typing of centrally located lung tumours |
95 |
||